# Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection

> **NCT07045688** · NA · RECRUITING · sponsor: **Sohag University** · enrollment: 150 (estimated)

## Conditions studied

- H. Pylori Infection

## Interventions

- **DRUG:** Efficacy of Vonoprazan based dual therapy for naive patient with Helicobacter Pylori infection
- **DRUG:** Efficacy of Vonoprazan based triple therapy for naive patient with Helicobacter Pylori infection
- **DRUG:** Efficacy of PPI based triple therapy for naive patient with Helicobacter Pylori infection

## Key facts

- **NCT ID:** NCT07045688
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-13
- **Primary completion:** 2025-11-25
- **Final completion:** 2025-11-25
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07045688

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07045688, "Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07045688. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*